supported by grants from the State Key Project of the National Natural Science Foundation of China(No.81730097);the Clinical Science and Technology Innovation Project of Shanghai Shenkang Hospital Development Center(Joint Project of Emerging Frontier Technology)(No.SHDC12018116);the Clinical Research Plan of Shanghai Hospital Development Center(No.SHDC2020CR1004A).
To the Editor:Primary liver cancer is one of the most common malignant tumors in China.In 2020,410,038 new cases of liver cancer and 391,152 deaths due to liver cancer were reported in China,which places liver cancer ...
Transarterial chemoembolization(TACE)is recommended as the first-line approach for intermediate hepatocellular carcinoma(HCC),and it is the most widely applied method for advanced HCC in real-world clinical practice.[...
supported by grants from the National Natural Science Foundation of China(Nos.92159202,82273270,and 32171368);National Science and Technology Major Project of China(No.2017ZX10203205).
As a radical treatment for hepatocellular carcinoma(HCC),liver transplantation(LT)has become an ideal treatment option for certain HCC patients.For patients beyond the Milan criteria,high HCC recurrence risk is a vita...
supported by grants from the National Natural Science Foundation of China(Nos.81900576,82100650);the Science and Technological Supports Project of Sichuan Province(Nos.2019YJ0149,22ZDYF1593);the Post-Doctor Research Project,West China Hospital,Sichuan University(No.2020HXBH069)
Serum hepatitis B virus deoxyribonucleic acid(HBVDNA)load is a critical index used to reflect the degree of viral replication in hepatocytes and to evaluate host hepatitis viral status.The risk of hepatocellular carci...
National Natural Science Foundation of China(Nos. 82070625, 81900576, and 81900463);Science and Technological Supports Project of Sichuan Province(No. 2020YFS0133);Post-Doctor Research Project, West China Hospital, Sichuan University(No. 2019HXBH004)
The incidence of hepatocellular carcinoma(HCC)is increasing year by year.The International Agency for Research on Cancer(IARC)reported that more than 630,000 people were diagnosed with HCC in 2020 and more than half o...
This study was supported by grants from the National Natural Science Foundation of China(Nos.81900463 and 81800449);the Science and Technological Supports Projectof SichuanProvince(No.2020YFS0133);Post-Doctor Research Project,West China Hospital,Sichuan University(No.2019HXBH004).
To the Editor:The incidence of hepatocellular carcinoma(HCC)with inferior vena cava tumor thrombus(IVCTT)is.approximately 1.4%.Owing to direct cancercll dissemination into the systemic circulation,HCC-IVCTT is frequen...
National Natural Science Foundation of China(No.81772273)。
To the Editor:Nowadays,many methods have been taken in early diagnosis and clinical therapy,but the overall survival(OS)of hepatocellular carcinoma(HCC)patients remains unsatisfactory.[1]Therefore,it is seriously sign...
To the Editor: A 62-year-old man came to our department and complained with progressively enlarging and bleeding multiple reddish nodules on his face for 20 days. The patient had a previous history of hepatitis B with...
grants from the National Natural Science Foundation of China(No.81201569 and No.81541151);the Beijing Natural Science Foundation(No.7132186);the National Key Sci-Tech Special Project of China(No.2018ZX10302207,No.2017ZX10203202).
Background:Our previous studies have shown that regulatory factor X5(RFX5),a classical transcription regulator of MHCⅡ genes,was obviously overexpressed in hepatocellular carcinoma(HCC)tumors.However,the role of RFX5...
grants from the National Natural Science Foundation of China(No.71603272);National Science and Technology Major Project(No.2017ZX10203205-001-005).
Background:Although a number of technical problems and donor safety issues associated with living donor liver transplantation(LDLT)have been resolved,some initial clinical studies showed an increased risk of hepatocel...